Acute Pancreatitis: Game-Changing Results in Fluid Resuscitation

United States News News

Acute Pancreatitis: Game-Changing Results in Fluid Resuscitation
United States Latest News,United States Headlines
  • 📰 Medscape
  • ⏱ Reading Time:
  • 60 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 55%

Early, aggressive fluid resuscitation in acute pancreatitis led to a higher incidence of fluid overload without improving clinical outcomes in the landmark WATERFALL trial.

led to a higher incidence of fluid overload without improving clinical outcomes in the landmark WATERFALL trial.

"This moderate fluid resuscitation strategy is associated with a much lower frequency of fluid overload and a trend toward improved outcomes. For such reasons, it should be considered as a new standard of care in the early management of acute pancreatitis," de-Madaria said.

A total of 249 patients were included in the interim analysis — 122 in the aggressive-resuscitation group and 127 in the moderate-resuscitation group. This clear signal of harm was coupled with no significant difference in the incidence of moderately severe or severe pancreatitis . "Unlike in most other randomized, controlled trials of fluid resuscitation in acute pancreatitis, patients with varying baseline pancreatitis severity were included, and changes in the rate of resuscitation were determined on the basis of a dynamic assessment of hemodynamic testing, imaging, and clinical factors," he adds.First, the need to focus on a steady rate of initial resuscitation — no more than 1.5 mL/kg of body weight per hour.

Gardner says the trial also highlights the need to focus research efforts on evaluating other pharmacologic therapies instead of crystalloid fluids.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Experimental Alzheimer's drug shows benefits in phase 3 trial, company saysExperimental Alzheimer's drug shows benefits in phase 3 trial, company saysJapanese drugmaker Eisai said cognitive function slowed over 18 months in patients who received the drug, called lecanemab.
Read more »

In Alex Jones trial, parents testify of pain inflicted by Sandy Hook deniersIn Alex Jones trial, parents testify of pain inflicted by Sandy Hook deniersIan Hockley, who lost his autistic son Dylan in the shooting, testified that he became the target of conspiracy theorists because he smiled during what he found as an uplifting memorial service.
Read more »

JetBlue CEO’s previous position on airline consolidation leads off antitrust trialJetBlue CEO’s previous position on airline consolidation leads off antitrust trialA trial is underway in the federal government’s lawsuit aiming to kill a partnership between American Airlines and JetBlue Airways in the Northeast.
Read more »

Jury selection begins in Oath Keepers' Jan. 6 conspiracy trialJury selection begins in Oath Keepers' Jan. 6 conspiracy trialThe trial, which is expected to last over a month, could prove to be the toughest test yet for prosecutors in the DOJ's sprawling investigation of the Jan. 6 attack, which has so far resulted in federal charges against nearly 900 defendants.
Read more »

Oath Keepers: Seditious Conspiracy Trial Puts Spotlight on Militia's Alleged Role in Capitol RiotOath Keepers: Seditious Conspiracy Trial Puts Spotlight on Militia's Alleged Role in Capitol RiotOnly a few days after Joe Biden's victory in the November 2020 presidential election, Oath Keepers militia founder Elmer Stewart Rhodes was already on InfoWars warning that the 'deep state' was trying to 'illegitimately' remove then-President Donald Trump. Rhodes laid out his militia’s plans in an interview with host Alex...
Read more »



Render Time: 2025-04-11 00:21:57